Servier Russia is located in Moscow and has been in operation since 2007. The site has one production unit that is dedicated to dry forms manufacturing.
As a part of the Servier Research Group, the Serdix site operates in accordance with the industrial strategy of the company and its culture of performance production, sharing experience, innovations and leading technological processes amongst the various production facilities in the group.
The high-tech cGMP production process complies with the highest international standards. The Serdix site manufactures drug product for the Russian market.
At the production site, pharmaceuticals are produced through all stages of development to packaging.
The manufacturing facility’s modern technology, equipment and design, as well as the use of materials from leading European pharmaceutical plants, ensure the production of high-quality and effective medications.
Our clients benefit from customized service and support for each stage of the project. We have the manufacturing capacity for your project and a dedicated team to help you.